Paediatrics Archives - Page 5 of 17 - Hospital Healthcare EuropeHospital Healthcare Europe

This website is intended for healthcare professionals only.

Paediatrics

New England Journal of Medicine publishes nusinersen Phase III CHERISH study results

New England Journal of Medicine publishes nusinersen Phase III CHERISH study results

CE marking of Eve™ CCHD Newborn Screening Application

CE marking of Eve™ CCHD Newborn Screening Application

Adalimumab biosimilar approved in Europe for the treatment of multiple chronic inflammatory diseases

Adalimumab biosimilar approved in Europe for the treatment of multiple chronic inflammatory diseases

Positive opinion to extend use of romiplostim in paediatric patients

Positive opinion to extend use of romiplostim in paediatric patients

First patient randomised in study evaluating safety and efficacy of anakinra in Still’s disease

First patient randomised in study evaluating safety and efficacy of anakinra in Still’s disease

Newborn Foundation and Masimo partnership reaches 52

Newborn Foundation and Masimo partnership reaches 52,000 babies and 1000 health workers

Full market release of rainbow acoustic monitoring sensor RAS-45

Full market release of rainbow acoustic monitoring sensor RAS-45

Guideline for the management of nut allergy helps to define diagnostic pathways, including the role of specific IgE testing

Positive CHMP opinion for adalimumab biosimilar

Positive CHMP opinion for adalimumab biosimilar

Management of childhood ITP

New guidance on diagnosis and management of allergic and non-allergic rhinitis published

Treating paediatric short bowel syndrome

Proposed rituximab and etanercept biosimilars recommended for approval in Europe

Proposed rituximab and etanercept biosimilars recommended for approval in Europe

Abeona Therapeutics Receives Orphan Drug Designation in EU for ABO-102

Abeona Therapeutics receives orphan drug designation in EU for ABO-102

NovoRapid® receives positive CHMP opinion for extended use in children as young as one year old

NovoRapid® receives positive CHMP opinion for extended use in children as young as one year old